Dermatology Diagnostic Devices and Therapeutics Market Size to Grow US$ 34.9 Billion By 2030

The global dermatology diagnostic devices and therapeutics market size was approximate at US$ 17.65 billion in 2022 and is anticipated to grow US$ 34.9 billion by 2030, registering a compound annual growth rate of 8.89% from 2022 to 2030.

The dermatology diagnostic devices and therapeutics market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the dermatology diagnostic devices and therapeutics market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the dermatology diagnostic devices and therapeutics report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the dermatology diagnostic devices and therapeutics market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2409

Dermatology Diagnostic Devices and Therapeutics Market  Report Scope 

Also read: U.S. Digital Therapeutics Market Size to Grow US$ 12.09 Billion By 2030

Research Approach

The comprehensive report on the global dermatology diagnostic devices and therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global dermatology diagnostic devices and therapeutics market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

• Canfield Scientific, Inc.
• Novartis International AG
• Valeant Pharmaceuticals International, Inc.
• gfa-Gevaert N.V.
• Galderma S.A.
• Michelson Diagnostics Ltd.
• Cutera, Inc.
• Astellas Pharma, Inc.
• Genentech
• GlaxoSmithKline plc
• LEO Pharma A/S
• Dino-Lite Europe/IDCP B.V.

Dermatology Diagnostic Devices and Therapeutics Market  Segmentations

By Diagnostic Devices

• Dermatoscopes
• Microscopes and Trichoscopes
• Imaging Equipment

By Application Class

• Diagnostic Devices
  • Skin Cancer Diagnosis
  • Other
• Treatment Devices
  • Hair Removal
  • Skin Rejuvenation
  • Acne, Psoriasis, and Tattoo Removal
  • Wrinkle Removal and Skin Resurfacing
  • Body Contouring and Fat Removal
  • Cellulite Reduction
  • Vascular and Pigmented Lesion Removal
  • Others

By End Use

• Hospitals
• Clinics
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dermatology Diagnostic Devices And Therapeutics Market 

5.1. COVID-19 Landscape: Dermatology Diagnostic Devices And Therapeutics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dermatology Diagnostic Devices And Therapeutics Market, By Diagnostic Devices

8.1. Dermatology Diagnostic Devices And Therapeutics Market, by Diagnostic Devices, 2022-2030

8.1.1 Dermatoscopes

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Microscopes and Trichoscopes

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Imaging Equipment

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Dermatology Diagnostic Devices And Therapeutics Market, By Application Class

9.1. Dermatology Diagnostic Devices And Therapeutics Market, by Application Class, 2022-2030

9.1.1. Diagnostic Devices

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Treatment Devices

Chapter 10. Global Dermatology Diagnostic Devices And Therapeutics Market, By End Use 

10.1. Dermatology Diagnostic Devices And Therapeutics Market, by End Use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Others

Chapter 11. Global Dermatology Diagnostic Devices And Therapeutics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.1.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.1.3. Market Revenue and Forecast, by End Use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.2.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.2.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End Use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.3.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.3.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End Use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.4.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End Use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End Use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.5.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.5.3. Market Revenue and Forecast, by End Use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End Use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application Class (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End Use (2017-2030)

Chapter 12. Company Profiles

12.1. Canfield Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Novartis International AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Valeant Pharmaceuticals International, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. gfa-Gevaert N.V.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Galderma S.A.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Michelson Diagnostics Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cutera, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Astellas Pharma, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Genentech

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. GlaxoSmithKline plc

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global dermatology diagnostic devices and therapeutics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for dermatology diagnostic devices and therapeutics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com